Co-designing a model for remote eye consultations with self-testing.
Official title: Co-designing and Evaluating a Real-world Implementation Model for Remote Consultation with Vision Self-testing. the ReVise Study.
Run by Cambridge University Hospitals NHS Foundation Trust · NCT05941182 · Data updated 2026-11-12
This study is trying to create a better way for people to have eye check-ups from home using self-testing, by working with patients and NHS staff to find out what might make it easier for everyone.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 4 Years and up |
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | Cambridge University Hospitals NHS Foundation Trust Academic / other |
| Locations | 2 sites (Cambridge, Cambridgeshire and 1 other locations) |
| Status | Recruiting |
| Started | September 3, 2023 |
| Main results expected | September 3, 2025 |
| Study ends | February 2, 2026 |
| Registry record updated | February 12, 2025 |
| Trial ID | NCT05941182 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include patients aged 4 years and older who are scheduled for follow-up remote eye consultations after an initial face-to-face visit.
✕Probably not a fit
Patients who refuse remote consultations or are converted to face-to-face appointments will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to co-design a scalable and sustainable implementation model for remote consultations in ophthalmic care, incorporating vision self-testing. It will involve patients, the public, and NHS staff to identify barriers to the uptake of remote consultations and develop strategies to overcome these challenges. The study will utilize a mixed methodology, collecting both qualitative and quantitative data from various stakeholders across three NHS eye departments. The implementation model will be tested in real-world settings to evaluate its effectiveness and sustainability.
Why it matters
Potential benefit: If successful, this study could enhance access to eye care by facilitating remote consultations and improving patient self-testing capabilities.
How similar studies have gone: Other studies have shown promise in implementing remote consultations in healthcare, but this specific co-design approach is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients 4 years and older scheduled by their clinician for a follow up remote eye clinic consultation following an initial face-to face consultation. Exclusion Criteria: -Patients refusing remote consultation or converted to a face-to-face appointment following scheduling.
Where it's running
-
Cambridge University Hospital NHS Trust
Cambridge, Cambridgeshire, United Kingdom Recruiting -
Manchester University Hospitals NHS Trust
Manchester, United Kingdom Recruiting
Study contacts
- Principal investigator: Louise Allen — Cambridge University Hospitals NHS Foundation Trust
- Study coordinator: Louise Allen
- Email: Louise.allen47@nhs.net
- Phone: 01223254665
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Dermal priming to boost flu vaccine response in people on B cell depletion
This study tests whether applying a topical cream with imiquimod on the skin around vaccination can boost the body’s response to the flu shot in people who are receiving B cell–depleting therapy.
-
Ginger as a Modifier of Ghrelin Levels in Parkinson’s Disease and REM Sleep Behavior Disorder
This study tests whether ginger capsules can raise ghrelin levels in people with Parkinson’s disease, REM sleep behavior disorder, and healthy controls.
-
Understanding how a wrist fracture heals and why some people develop long-lasting pain
This study tests whether genetic markers, blood signals, heart-rate patterns, and brain body maps can predict which patients will have persistent pain after a distal radius fracture.
-
Belzutifan and catecholamine metabolism in pheochromocytoma/paraganglioma
This study tests whether Belzutifan can change how catecholamines are produced and broken down in adults with pheochromocytoma or paraganglioma.
-
Low-dose IL-2 after heart attack to study tissue-resident regulatory T cells
Researchers are testing whether low-dose interleukin-2 given after a myocardial infarction can boost tissue-resident regulatory T cells to support heart repair.
-
Metabolic testing in people with vascular Ehlers-Danlos syndrome
This project will test whether people with vascular Ehlers-Danlos syndrome have problems with how their bodies store and use fat that could lead to insulin resistance or diabetes.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.